Home LOCAL NEWS RECALL ALERT: Blood pressure medications with trace amounts of carcinogen

RECALL ALERT: Blood pressure medications with trace amounts of carcinogen

by MyParisTexas
0 comment

More blood pressure medication is being recalled for trace amounts of a carcinogen.

Forty repackaged lots of Losartan Tablets USP 25mg, 50mg, and 100mg were voluntarily recalled on March 15.

“This recall was prompted due to Torrent Pharmaceuticals LTD issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, (API manufacturer),” according to the FDA. 

Three lots of Losartan Tablets USP 50mg also were voluntarily recalled on March 15.

Losartan Potassium USP is used to treat high blood pressure and congestive heart failure. It is packaged in 30-count bottles.

These recalls are in addition to five other recalls associated with blood pressure medication. Here is the full list:

  1. Valsartan and Amlodipine and Valsartan tablets
  2. Valsartan Tablets USP
  3. Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide Tablets USP
  4. Losartan Tablets USP 25 mg, 50 mg, and 100 mg
  5. Losartan Potassium/Hydrochlorothiazide Combination Tablets

FDA said patients are instructed to return all recalled products to the dispensing pharmacy. These products were distributed nationwide.

See the full list of recalls here

Related Articles